Summary information and primary citation
- PDB-id
-
8k8u;
DSSR-derived features in text and
JSON formats
- Class
- viral protein-DNA
- Method
- cryo-EM (3.05 Å)
- Summary
- F8-a22-e4 complex of mpxv in complex with DNA and
dctp
- Reference
-
Shen Y, Li Y, Yan R (2024): "Structural
basis for the inhibition mechanism of the DNA polymerase
holoenzyme from mpox virus." Structure,
32, 654-661.e3. doi: 10.1016/j.str.2024.03.004.
- Abstract
- There are three key components at the core of the mpox
virus (MPXV) DNA polymerase holoenzyme: DNA polymerase F8,
processivity factors A22, and the Uracil-DNA glycosylase
E4. The holoenzyme is recognized as a vital antiviral
target because MPXV replicates in the cytoplasm of host
cells. Nucleotide analogs such as cidofovir and cytarabine
(Ara-C) have shown potential in curbing MPXV replication
and they also display promise against other poxviruses.
However, the mechanism behind their inhibitory effects
remains unclear. Here, we present the cryo-EM structure of
the DNA polymerase holoenzyme F8/A22/E4 bound with its
competitive inhibitor Ara-C-derived cytarabine triphosphate
(Ara-CTP) at an overall resolution of 3.0 Å and reveal
its inhibition mechanism. Ara-CTP functions as a direct
chain terminator in proximity to the deoxycytidine
triphosphate (dCTP)-binding site. The extra hydrogen bond
formed with Asn665 makes it more potent in binding than
dCTP. Asn665 is conserved among eukaryotic B-family
polymerases.